 | • レポートコード：MR2211MG12684 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、71ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、医療用局所止血剤のグローバル市場規模と予測を記載しています。・医療用局所止血剤のグローバル市場：売上、2017年-2022年、2023年-2028年 ・医療用局所止血剤のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 医療用局所止血剤のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「ゲル化スポンジ」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 医療用局所止血剤のグローバル主要企業は、Ethicon、 Pfizer、 Baxter International、 C. R. Bard、 The Medicines Company、 Anika Therapeutics、 Advanced Medical Solutions、 Integra LifeSciences、 B Braun Melsungen、 Gelita Medical、 Equimedical、 Vascular Solutions、 Marine Polymer Technologiesなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、医療用局所止血剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の医療用局所止血剤市場：タイプ別、2017年-2022年、2023年-2028年 世界の医療用局所止血剤市場：タイプ別市場シェア、2021年 ・ゲル化スポンジ、酸化再生セルロース系止血材、その他 世界の医療用局所止血剤市場：用途別、2017年-2022年、2023年-2028年 世界の医療用局所止血剤市場：用途別市場シェア、2021年 ・病院、外科センター、老人ホーム 世界の医療用局所止血剤市場：地域・国別、2017年-2022年、2023年-2028年 世界の医療用局所止血剤市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における医療用局所止血剤のグローバル売上、2017年-2022年 ・主要企業における医療用局所止血剤のグローバル売上シェア、2021年 ・主要企業における医療用局所止血剤のグローバル販売量、2017年-2022年 ・主要企業における医療用局所止血剤のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Ethicon、 Pfizer、 Baxter International、 C. R. Bard、 The Medicines Company、 Anika Therapeutics、 Advanced Medical Solutions、 Integra LifeSciences、 B Braun Melsungen、 Gelita Medical、 Equimedical、 Vascular Solutions、 Marine Polymer Technologies ************************************************************* ・調査・分析レポートの概要 医療用局所止血剤市場の定義 市場セグメント 世界の医療用局所止血剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医療用局所止血剤市場規模 世界の医療用局所止血剤市場規模：2021年 VS 2028年 世界の医療用局所止血剤市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医療用局所止血剤の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の医療用局所止血剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ゲル化スポンジ、酸化再生セルロース系止血材、その他 医療用局所止血剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、外科センター、老人ホーム 医療用局所止血剤の用途別グローバル売上・予測 ・地域別市場分析 地域別医療用局所止血剤市場規模 2021年と2028年 地域別医療用局所止血剤売上・予測 北米市場 - アメリカの医療用局所止血剤市場規模2017年-2028年 - カナダの医療用局所止血剤市場規模2017年-2028年 - メキシコの医療用局所止血剤市場規模2017年-2028年 ヨーロッパ市場 - ドイツの医療用局所止血剤市場規模2017年-2028年 - フランスの医療用局所止血剤市場規模2017年-2028年 - イギリスの医療用局所止血剤市場規模2017年-2028年 - イタリアの医療用局所止血剤市場規模2017年-2028年 - ロシアの医療用局所止血剤市場規模2017年-2028年 アジア市場 - 中国の医療用局所止血剤市場規模2017年-2028年 - 日本の医療用局所止血剤市場規模2017年-2028年 - 韓国の医療用局所止血剤市場規模2017年-2028年 - 東南アジアの医療用局所止血剤市場規模2017年-2028年 - インドの医療用局所止血剤市場規模2017年-2028年 南米市場 - ブラジルの医療用局所止血剤市場規模2017年-2028年 - アルゼンチンの医療用局所止血剤市場規模2017年-2028年 中東・アフリカ市場 - トルコの医療用局所止血剤市場規模2017年-2028年 - イスラエルの医療用局所止血剤市場規模2017年-2028年 - サウジアラビアの医療用局所止血剤市場規模2017年-2028年 - UAEの医療用局所止血剤市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Ethicon、 Pfizer、 Baxter International、 C. R. Bard、 The Medicines Company、 Anika Therapeutics、 Advanced Medical Solutions、 Integra LifeSciences、 B Braun Melsungen、 Gelita Medical、 Equimedical、 Vascular Solutions、 Marine Polymer Technologies ... |
Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
This report contains market size and forecasts of Medical Topical Hemostatic Agent in global, including the following market information:
Global Medical Topical Hemostatic Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Topical Hemostatic Agent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Medical Topical Hemostatic Agent companies in 2021 (%)
The global Medical Topical Hemostatic Agent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gelation Sponge Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Topical Hemostatic Agent include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Topical Hemostatic Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Topical Hemostatic Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, by Type, 2021 (%)
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Global Medical Topical Hemostatic Agent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, by Application, 2021 (%)
Hospitals
Surgical Centers
Nursing Homes
Global Medical Topical Hemostatic Agent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Topical Hemostatic Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medical Topical Hemostatic Agent revenues share in global market, 2021 (%)
Key companies Medical Topical Hemostatic Agent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Medical Topical Hemostatic Agent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
1 Introduction to Research & Analysis Reports
1.1 Medical Topical Hemostatic Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Topical Hemostatic Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Topical Hemostatic Agent Overall Market Size
2.1 Global Medical Topical Hemostatic Agent Market Size: 2021 VS 2028
2.2 Global Medical Topical Hemostatic Agent Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Medical Topical Hemostatic Agent Sales: 2017-2028
3 Company Landscape
3.1 Top Medical Topical Hemostatic Agent Players in Global Market
3.2 Top Global Medical Topical Hemostatic Agent Companies Ranked by Revenue
3.3 Global Medical Topical Hemostatic Agent Revenue by Companies
3.4 Global Medical Topical Hemostatic Agent Sales by Companies
3.5 Global Medical Topical Hemostatic Agent Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Medical Topical Hemostatic Agent Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Medical Topical Hemostatic Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Topical Hemostatic Agent Players in Global Market
3.8.1 List of Global Tier 1 Medical Topical Hemostatic Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Topical Hemostatic Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Topical Hemostatic Agent Market Size Markets, 2021 & 2028
4.1.2 Gelation Sponge
4.1.3 Oxidized Regenerated Cellulose Based Hemostats
4.1.4 Others
4.2 By Type – Global Medical Topical Hemostatic Agent Revenue & Forecasts
4.2.1 By Type – Global Medical Topical Hemostatic Agent Revenue, 2017-2022
4.2.2 By Type – Global Medical Topical Hemostatic Agent Revenue, 2023-2028
4.2.3 By Type – Global Medical Topical Hemostatic Agent Revenue Market Share, 2017-2028
4.3 By Type – Global Medical Topical Hemostatic Agent Sales & Forecasts
4.3.1 By Type – Global Medical Topical Hemostatic Agent Sales, 2017-2022
4.3.2 By Type – Global Medical Topical Hemostatic Agent Sales, 2023-2028
4.3.3 By Type – Global Medical Topical Hemostatic Agent Sales Market Share, 2017-2028
4.4 By Type – Global Medical Topical Hemostatic Agent Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Medical Topical Hemostatic Agent Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Surgical Centers
5.1.4 Nursing Homes
5.2 By Application – Global Medical Topical Hemostatic Agent Revenue & Forecasts
5.2.1 By Application – Global Medical Topical Hemostatic Agent Revenue, 2017-2022
5.2.2 By Application – Global Medical Topical Hemostatic Agent Revenue, 2023-2028
5.2.3 By Application – Global Medical Topical Hemostatic Agent Revenue Market Share, 2017-2028
5.3 By Application – Global Medical Topical Hemostatic Agent Sales & Forecasts
5.3.1 By Application – Global Medical Topical Hemostatic Agent Sales, 2017-2022
5.3.2 By Application – Global Medical Topical Hemostatic Agent Sales, 2023-2028
5.3.3 By Application – Global Medical Topical Hemostatic Agent Sales Market Share, 2017-2028
5.4 By Application – Global Medical Topical Hemostatic Agent Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Medical Topical Hemostatic Agent Market Size, 2021 & 2028
6.2 By Region – Global Medical Topical Hemostatic Agent Revenue & Forecasts
6.2.1 By Region – Global Medical Topical Hemostatic Agent Revenue, 2017-2022
6.2.2 By Region – Global Medical Topical Hemostatic Agent Revenue, 2023-2028
6.2.3 By Region – Global Medical Topical Hemostatic Agent Revenue Market Share, 2017-2028
6.3 By Region – Global Medical Topical Hemostatic Agent Sales & Forecasts
6.3.1 By Region – Global Medical Topical Hemostatic Agent Sales, 2017-2022
6.3.2 By Region – Global Medical Topical Hemostatic Agent Sales, 2023-2028
6.3.3 By Region – Global Medical Topical Hemostatic Agent Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Medical Topical Hemostatic Agent Revenue, 2017-2028
6.4.2 By Country – North America Medical Topical Hemostatic Agent Sales, 2017-2028
6.4.3 US Medical Topical Hemostatic Agent Market Size, 2017-2028
6.4.4 Canada Medical Topical Hemostatic Agent Market Size, 2017-2028
6.4.5 Mexico Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Medical Topical Hemostatic Agent Revenue, 2017-2028
6.5.2 By Country – Europe Medical Topical Hemostatic Agent Sales, 2017-2028
6.5.3 Germany Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.4 France Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.5 U.K. Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.6 Italy Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.7 Russia Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.8 Nordic Countries Medical Topical Hemostatic Agent Market Size, 2017-2028
6.5.9 Benelux Medical Topical Hemostatic Agent Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Medical Topical Hemostatic Agent Revenue, 2017-2028
6.6.2 By Region – Asia Medical Topical Hemostatic Agent Sales, 2017-2028
6.6.3 China Medical Topical Hemostatic Agent Market Size, 2017-2028
6.6.4 Japan Medical Topical Hemostatic Agent Market Size, 2017-2028
6.6.5 South Korea Medical Topical Hemostatic Agent Market Size, 2017-2028
6.6.6 Southeast Asia Medical Topical Hemostatic Agent Market Size, 2017-2028
6.6.7 India Medical Topical Hemostatic Agent Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Medical Topical Hemostatic Agent Revenue, 2017-2028
6.7.2 By Country – South America Medical Topical Hemostatic Agent Sales, 2017-2028
6.7.3 Brazil Medical Topical Hemostatic Agent Market Size, 2017-2028
6.7.4 Argentina Medical Topical Hemostatic Agent Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Topical Hemostatic Agent Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Medical Topical Hemostatic Agent Sales, 2017-2028
6.8.3 Turkey Medical Topical Hemostatic Agent Market Size, 2017-2028
6.8.4 Israel Medical Topical Hemostatic Agent Market Size, 2017-2028
6.8.5 Saudi Arabia Medical Topical Hemostatic Agent Market Size, 2017-2028
6.8.6 UAE Medical Topical Hemostatic Agent Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Ethicon
7.1.1 Ethicon Corporate Summary
7.1.2 Ethicon Business Overview
7.1.3 Ethicon Medical Topical Hemostatic Agent Major Product Offerings
7.1.4 Ethicon Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.1.5 Ethicon Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Medical Topical Hemostatic Agent Major Product Offerings
7.2.4 Pfizer Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Baxter International
7.3.1 Baxter International Corporate Summary
7.3.2 Baxter International Business Overview
7.3.3 Baxter International Medical Topical Hemostatic Agent Major Product Offerings
7.3.4 Baxter International Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.3.5 Baxter International Key News
7.4 C. R. Bard
7.4.1 C. R. Bard Corporate Summary
7.4.2 C. R. Bard Business Overview
7.4.3 C. R. Bard Medical Topical Hemostatic Agent Major Product Offerings
7.4.4 C. R. Bard Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.4.5 C. R. Bard Key News
7.5 The Medicines Company
7.5.1 The Medicines Company Corporate Summary
7.5.2 The Medicines Company Business Overview
7.5.3 The Medicines Company Medical Topical Hemostatic Agent Major Product Offerings
7.5.4 The Medicines Company Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.5.5 The Medicines Company Key News
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Corporate Summary
7.6.2 Anika Therapeutics Business Overview
7.6.3 Anika Therapeutics Medical Topical Hemostatic Agent Major Product Offerings
7.6.4 Anika Therapeutics Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.6.5 Anika Therapeutics Key News
7.7 Advanced Medical Solutions
7.7.1 Advanced Medical Solutions Corporate Summary
7.7.2 Advanced Medical Solutions Business Overview
7.7.3 Advanced Medical Solutions Medical Topical Hemostatic Agent Major Product Offerings
7.7.4 Advanced Medical Solutions Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.7.5 Advanced Medical Solutions Key News
7.8 Integra LifeSciences
7.8.1 Integra LifeSciences Corporate Summary
7.8.2 Integra LifeSciences Business Overview
7.8.3 Integra LifeSciences Medical Topical Hemostatic Agent Major Product Offerings
7.8.4 Integra LifeSciences Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.8.5 Integra LifeSciences Key News
7.9 B Braun Melsungen
7.9.1 B Braun Melsungen Corporate Summary
7.9.2 B Braun Melsungen Business Overview
7.9.3 B Braun Melsungen Medical Topical Hemostatic Agent Major Product Offerings
7.9.4 B Braun Melsungen Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.9.5 B Braun Melsungen Key News
7.10 Gelita Medical
7.10.1 Gelita Medical Corporate Summary
7.10.2 Gelita Medical Business Overview
7.10.3 Gelita Medical Medical Topical Hemostatic Agent Major Product Offerings
7.10.4 Gelita Medical Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.10.5 Gelita Medical Key News
7.11 Equimedical
7.11.1 Equimedical Corporate Summary
7.11.2 Equimedical Medical Topical Hemostatic Agent Business Overview
7.11.3 Equimedical Medical Topical Hemostatic Agent Major Product Offerings
7.11.4 Equimedical Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.11.5 Equimedical Key News
7.12 Vascular Solutions
7.12.1 Vascular Solutions Corporate Summary
7.12.2 Vascular Solutions Medical Topical Hemostatic Agent Business Overview
7.12.3 Vascular Solutions Medical Topical Hemostatic Agent Major Product Offerings
7.12.4 Vascular Solutions Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.12.5 Vascular Solutions Key News
7.13 Marine Polymer Technologies
7.13.1 Marine Polymer Technologies Corporate Summary
7.13.2 Marine Polymer Technologies Medical Topical Hemostatic Agent Business Overview
7.13.3 Marine Polymer Technologies Medical Topical Hemostatic Agent Major Product Offerings
7.13.4 Marine Polymer Technologies Medical Topical Hemostatic Agent Sales and Revenue in Global (2017-2022)
7.13.5 Marine Polymer Technologies Key News
8 Global Medical Topical Hemostatic Agent Production Capacity, Analysis
8.1 Global Medical Topical Hemostatic Agent Production Capacity, 2017-2028
8.2 Medical Topical Hemostatic Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Topical Hemostatic Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Topical Hemostatic Agent Supply Chain Analysis
10.1 Medical Topical Hemostatic Agent Industry Value Chain
10.2 Medical Topical Hemostatic Agent Upstream Market
10.3 Medical Topical Hemostatic Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Topical Hemostatic Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer